Walgreens Boots Alliance Inc. buy gerihouse
Summary
This prediction ended on 12.08.15 with a price of €83.00. With a performance of 9.39%, the BUY prediction by gerihouse for Walgreens Boots Alliance Inc. closed with a slight gain. gerihouse has 50% into this predictionWalgreens Boots Alliance (Symbol: WBA) (WKN: A12HJF) is a leading global pharmacy retail and healthcare company, listed on the stock exchange, with a presence in several countries worldwide. Founded in 2014 following the merger of Walgreens and Alliance Boots, the company's operations span across three core divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. As a pioneer in the pharmacy sector, WBA offers a diverse range of products and services, including prescription medications, over-the-counter drugs, beauty and personal care items, as well as various in-store health services. Its extensive network of physical locations and innovative e-commerce platforms enables WBA to reach millions of customers, while also participating in strategic joint ventures and partnerships to strengthen its market position. With a strong commitment to social responsibility and sustainability, Walgreens Boots Alliance has positioned itself as a major player in the ever-evolving global healthcare landscape, dedicated to improving the lives of the communities it serves.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Walgreens Boots Alliance Inc. | -1.744% | -1.744% | -47.470% | -61.362% |
iShares Core DAX® | 0.961% | -2.210% | 12.839% | 17.154% |
iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% | 45.463% |
iShares Nikkei 225® | 0.217% | -7.216% | 19.425% | 5.076% |
iShares S&P 500 | 1.540% | -1.858% | 27.801% | 42.583% |
According to gerihouse what are the pros and cons of Walgreens Boots Alliance Inc. for the foreseeable future?
Pros
Cons
Comments by gerihouse for this prediction
In the thread Walgreens Boots Alliance Inc. diskutieren
Kaufen
Wieder kaufenswert!Equities researchers at Macquarie assumed coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA) in a research report issued on Tuesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $95.00 price target on the pharmacy operator’s stock. Macquarie’s price objective would suggest a potential upside of 12.87% from the stock’s previous close.
Walgreens Boots Alliance (NASDAQ:WBA) opened at 84.17 on Tuesday. Walgreens Boots Alliance has a 52-week low of $57.75 and a 52-week high of $93.42. The stock has a 50-day moving average of $85. and a 200-day moving average of $80..
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings data on Thursday, April 9th. The pharmacy operator reported $1.18 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.94 by $0.24. The company had revenue of $26.60 billion for the quarter, compared to the consensus estimate of $27.27 billion. During the same quarter in the prior year, the company posted $0.91 earnings per share. The company’s quarterly revenue was up 35.5% on a year-over-year basis. Analysts expect that Walgreens Boots Alliance will post $3.63 EPS for the current fiscal year.
Stopped prediction by gerihouse for Walgreens Boots Alliance Inc.
Walgreens Boots Alliance Inc.
27.05.20
04.11.21
12.01.21
Walgreens Boots Alliance Inc.
18.03.20
01.04.20
01.04.20
Walgreens Boots Alliance Inc.
24.09.19
13.02.20
13.02.20
Walgreens Boots Alliance Inc.
23.04.19
29.05.19
29.05.19
Walgreens Boots Alliance Inc.
24.03.15
17.04.15
17.04.15